The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 163:52-58, January 2006
doi: 10.1176/appi.ajp.163.1.52
© 2006 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Full Text (Publish Ahead of Print[PDF])
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Parsey, R. V.
* Articles by Mann, J. J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Parsey, R. V.
* Articles by Mann, J. J.
Related Collections
* Neurotransmitters
* Depression
*Related Article

Lower Serotonin Transporter Binding Potential in the Human Brain During Major Depressive Episodes

Ramin V. Parsey, M.D., Ph.D., Ramin S. Hastings, B.S., Maria A. Oquendo, M.D., Yung-yu Huang, M.S., Norman Simpson, B.S., Julie Arcement, B.S., Yiyun Huang, Ph.D., R. Todd Ogden, Ph.D., Ronald L. Van Heertum, M.D., Victoria Arango, Ph.D., and J. John Mann, M.D.

OBJECTIVE: CSF analysis, neuroendocrine challenges, serotonin depletion studies, and treatment studies implicate the serotonergic system in the pathophysiology of major depressive disorder. On the basis of postmortem and imaging studies, the authors hypothesized that subjects with major depressive disorder in a major depressive episode have fewer serotonin transporter sites, compared with healthy subjects. METHOD: Serotonin transporter binding potential (f1Bmax/Kd) was determined using positron emission tomography with [11C]McN 5652 in six brain regions in 25 medication-free subjects with DSM-IV major depressive disorder during a major depressive episode and in 43 healthy volunteer comparison subjects. All subjects had arterial lines placed to determine metabolite-corrected arterial input functions. RESULTS: Serotonin transporter binding potential differed significantly by brain region and group. Post hoc analysis revealed lower binding potential in subjects with major depressive disorder, relative to the comparison subjects, in the amygdala and midbrain. The lower binding potential was more pronounced in the depressed subjects who had never received antidepressants. No correlation was found between binding potential in the midbrain and severity of depression or number of days without medication. Binding potential did not differ between suicide attempters and nonattempters. CONCLUSIONS: Subjects in a major depressive episode have lower serotonin transporter binding potential in the amygdala and midbrain, compared to healthy subjects.


Related Article:

In This Issue
Am J Psychiatry 2006 163: A34. [Full Text] [PDF]



This article has been cited by other articles:


Home page
JNMHome page
M. Slifstein
Revisiting an Old Issue: The Discrepancy Between Tissue Ratio-Derived Binding Parameters and Kinetic Modeling-Derived Parameters After a Bolus of the Serotonin Transporter Radioligand 123I-ADAM
J. Nucl. Med., February 1, 2008; 49(2): 176 - 178.
[Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
Z. Bhagwagar, N. Murthy, S. Selvaraj, R. Hinz, M. Taylor, S. Fancy, P. Grasby, and P. Cowen
5-HTT Binding in Recovered Depressed Patients and Healthy Volunteers: A Positron Emission Tomography Study With [11C]DASB
Am J Psychiatry, December 1, 2007; 164(12): 1858 - 1865.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
R. V. Parsey, A. Ojha, R. T. Ogden, K. Erlandsson, D. Kumar, M. Landgrebe, R. Van Heertum, and J. J. Mann
Metabolite Considerations in the In Vivo Quantification of Serotonin Transporters Using 11C-DASB and PET in Humans
J. Nucl. Med., November 1, 2006; 47(11): 1796 - 1802.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
A. Neumeister, X.-Z. Hu, D. A. Luckenbaugh, M. Schwarz, A. C. Nugent, O. Bonne, P. Herscovitch, D. Goldman, W. C. Drevets, and D. S. Charney
Differential Effects of 5-HTTLPR Genotypes on the Behavioral and Neural Responses to Tryptophan Depletion in Patients With Major Depression and Controls.
Arch Gen Psychiatry, September 1, 2006; 63(9): 978 - 986.
[Abstract] [Full Text] [PDF]


Home page
JWatch PsychiatryHome page
Emerging Perspectives: New Stories of How Genes and Life Events Interact in Depression
Journal Watch Psychiatry, January 25, 2006; 2006(125): 1 - 1.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org